SHENAKWA HAWKINS: Open Payments
NPI 1306384086 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 5 companies in 2025. Trend: 2023 $44 · 2024 $21 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $48 |
| Exact Sciences Corporation | 2 | $37 |
| Astellas Pharma US Inc | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: Rybelsus, Cologuard Collection Kit, Veozah, ACCRUFER, GVOKE HYPOPEN.
Industry payments across NV — which companies pay providers there.
